In another study where patients with CHF received resynchronization therapy, hyponatremia was noted to be an independent predictor for the worsening of heart failure after the implantation of the resynchronization device, alteration that could be partially explained by the rising levels of arginine vasopressin [16]. This evidence concerns the gene AVP and heart failure.